ETFIQData as of Nov 18, 2026. · etfiq.com/funds/ixjDownload PDF

IXJ Fact Sheet: iShares Global Healthcare ETF

Share
$110.70
close, Nov 18, 2026

Over the year to Nov 18, 2026, IXJ returned +17.2% in total and charged 0.38% a year.

1-year total return
+17.2%
to Nov 18, 2026
Expense ratio
0.38%
a year
Net assets
$4.6bn
on Nov 18, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

IXJ $11,723 +17.2% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+4.0%
3 months+3.1%
Year to date+14.7%
1 year+17.2%
3 years+40.9%
5 years+36.6%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
ELI LILLY & COMPANY11.60%
JOHNSON & JOHNSON6.88%
ABBVIE5.30%
MERCK & CO INC3.98%
UNITEDHEALTH GROUP3.94%
ROCHE PS PAR AG3.83%
NOVARTIS AG3.28%
ASTRAZENECA PLC3.18%
THERMO FISHER SCIENTIFIC2.86%
AMGEN INC2.79%

IXJ top ten by weight, 47.6% of the fund, of its 110 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P Global 1200 Health Care Index · First traded Nov 26, 2001 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, IXJ Fact Sheet: iShares Global Healthcare ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/ixj/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/ixj.